MCRB SERES THERAPEUTICS INC Disposals and divestitures 8-K Filing 2024 - Business Sale Seres Therapeutics completed the sale of its VOWST microbiome therapeutic business to Nestlé for $100 million, plus future milestone payments, and entered into several related agreements including a transition services agreement and a securities purchase agreement for $15 million.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC